BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

18 related articles for article (PubMed ID: 38623659)

  • 1. Performance evaluation of CA242 by flow fluorescence assay.
    Hou Y; Chen Y; Sun J; Geng J; Jin H; Zhang Z
    Medicine (Baltimore); 2021 Apr; 100(15):e25301. PubMed ID: 33847629
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Performance Evaluation of a Newly Developed Chemiluminescent Assay Kit for Detection of Neuron-Specific Eno.
    Qing L; Chun-Lei Y; Hui-Ming Y; Hong-Wei J; Zhi-Yuan L; Yan-Ling L; Hong-Wei L; Yang Y; Shui-Di Y; Yong-Zhi L; Jiang-Wu L; Zu-Xing W; Yi-Juan C; Zhong-Ying Z
    Clin Lab; 2018 Jul; 64(7):1233-1240. PubMed ID: 30146825
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Performance verification of five commercial RT-qPCR diagnostic kits for SARS-CoV-2.
    Yang M; Cao S; Liu Y; Zhang Z; Zheng R; Li Y; Zhou J; Zong C; Cao D; Qin X
    Clin Chim Acta; 2022 Jan; 525():46-53. PubMed ID: 34902345
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Performance verification and clinical application evaluation of D-dimer assay].
    Chen Q; Shou WL; Fang JY; Zhang L; Guo Y
    Zhonghua Yi Xue Za Zhi; 2023 Dec; 103(47):3828-3834. PubMed ID: 38123224
    [No Abstract]   [Full Text] [Related]  

  • 5. Evaluation of a newly developed quantitative determination kit for tumor marker CA15-3 with chemiluminescent assay.
    Li P; Ye H; Liu J; Jin H; Lin Y; Yan S; Yu Y; Gao L; Xu F; Zhang Z
    J Clin Lab Anal; 2018 Jan; 32(1):. PubMed ID: 28233344
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Performance Evaluation of Newly-Developed Tumor Markers Assay Kit Based on Flow Fluorescence Assay.
    Jiang Y; Li Z; Li Z; Shi X; Chang L; Yan C
    Clin Lab; 2024 Apr; 70(4):. PubMed ID: 38623659
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Problems related to determination of reference interval and clinical decision limit in enzyme immunoassay].
    Ichihara K
    Nihon Rinsho; 1995 Sep; 53(9):2220-30. PubMed ID: 7474385
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Insights in the application of research-grade diagnostic kits for biomarker assessments in support of clinical drug development: bioanalysis of circulating concentrations of soluble receptor activator of nuclear factor kappaB ligand.
    Bowsher RR; Sailstad JM
    J Pharm Biomed Anal; 2008 Dec; 48(5):1282-9. PubMed ID: 18977625
    [TBL] [Abstract][Full Text] [Related]  

  • 9.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 10.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 11.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 12.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 13.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 14.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 15.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 16.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 17.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 18.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 1.